Search
Search Results
-
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus
BackgroundThe prognosis of cirrhosis is clearly stratified by liver function. Although direct-acting antiviral (DAA) has recently been used to...
-
Partial splenic embolization improved stomal varices in patient with decompensated liver cirrhosis: a case report
A 63-year-old man with decompensated liver cirrhosis was admitted for treatment of stomal hemorrhage. Eighteen months earlier, he was diagnosed with...
-
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis
Patients with chronic hepatitis C virus (HCV) infection and decompensated cirrhosis are an important population for antiviral therapy yet...
-
Acute Kidney Injury in Acute on Chronic Liver Failure Versus Decompensated Cirrhosis—What Is the Difference?
Purpose of ReviewHepatorenal syndrome (HRS), the severe manifestation of renal injury in patients with cirrhosis and acute on chronic liver failure...
-
Association Between Bowel Wall Thickening and Long-Term Outcomes in Decompensated Liver Cirrhosis
IntroductionBowel wall thickening is commonly observed in liver cirrhosis, but few studies have explored its impact on the long-term outcomes of...
-
Validity of serum leukotriene B4 as a marker of decompensated liver cirrhosis in chronic HCV patients: leukotriene B4 in decompensated liver cirrhosis
BackgroundLiver cirrhosis is divided into two stages: compensated stage and another advanced stage which includes both decompensated cirrhosis and...
-
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
Background or PurposeAlthough human umbilical cord blood-derived mesenchymal stem cell transplantation (HUCB-MSCT) resulted in a good short-term...
-
Validity of serum resistin level and Il-6 as prognostic biomarkers of decompensated liver cirrhosis in chronic hepatitis C virus patients
BackgroundDecompensated liver cirrhosis (DLC) is now known as a chronic inflammatory process, evidenced by elevated levels of circulatory...
-
Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis
IntroductionPatients with chronic hepatitis B (CHB) have a dynamic disease process and risk of end-stage liver disease. It is critical to...
-
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
Background and aimSince hepatocytes produce majority of serum proteins, patients with cirrhosis display substantial alterations in the serum...
-
Efficacy of long-term albumin therapy in the treatment of decompensated cirrhosis
Background and AimsDecompensated liver cirrhosis has a poor prognosis, with a median overall survival of two to four years, which is worse than for...
-
A case of recurrent follicular cholangitis leading to decompensated cirrhosis after left-sided hepatectomy
Follicular cholangitis (FC) is a rare non-neoplastic biliary tract disease first reported in 2003. A 74-year-old woman underwent extended left...
-
Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study
BackgroundPrior assessments of critical care outcomes in patients with cirrhosis have shown conflicting results. We aimed to provide nationwide...
-
The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis
ObjectivesTo determine the value of periportal hyperintensity sign from gadobenate dimeglumine (Gd-BOPTA)-enhanced hepatobiliary phase (HBP) magnetic...
-
To evaluate the prevalence of spontaneous portosystemic shunts in decompensated cirrhosis patients and its prognostic significance
IntroductionSpontaneous portosystemic shunts (SPSS) are frequent in liver cirrhosis and their prevalence increases as liver function deteriorates,...
-
Echocardiographic hemodynamic assessment in decompensated cirrhosis: comparison between Intensivists and Gastroenterologists
Background & aims: Ascites is a frequent complication of cirrhosis. In intensive care units, initial hemodynamic assessment is frequently performed...
-
Fat mass: a novel digital biomarker for remote monitoring that may indicate risk for malnutrition and new complications in decompensated cirrhosis
BackgroundCirrhosis is associated with sarcopaenia and fat wasting, which drive decompensation and mortality. Currently, nutritional status, through...
-
Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia
BackgroundAcutely decompensated liver cirrhosis is associated with high medical costs and negatively affects productivity and quality of life. Data...
-
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)
BackgroundWe developed a nationwide database that stores data of patients with primary liver cancer (PLC) and decompensated cirrhosis (DC) on an...
-
Successful prolonged treatment with sofosbuvir/velpatasvir for a hepatitis C patient with decompensated cirrhosis and treatment failure after 12-week therapy
There is no established rescue therapy for hepatitis C patients with decompensated cirrhosis who experience treatment failure on 12-week sofosbuvir...
